Department of Bioengineering and Therapeutic Sciences

Consortium inventing medical devices for children gets new funding

Thu Nov 10, 2011
Roy
© majedphoto.com

Shuvo Roy, PhD

A two-year-old, cross-disciplinary effort to invent new medical devices for children, co-founded by bioengineer Shuvo Roy, PhD, has received a two-year $1 million grant from the U.S. Food and Drug Administration (FDA) to expand its work.

Drugs screened for effects on key transporters, risk of dangerous interactions

Tue Nov 8, 2011
diagram

UCSF scientists are studying key drug transporters that play roles in drug absorption and elimination. Shown here: OCT2 and others in the membrane of cells in the kidney tubules (at right). The urine collecting tubules interface with capillaries (at left) to remove substances such as medications and environmental toxins from the blood.

To reduce the risk of toxic drug interactions, UCSF's Kathy Giacomini, PhD, and colleagues are screening thousands of prescription drugs, testing how much they inhibit key proteins in kidney and liver cell

Nordberg becomes associate dean, finance and administration

Fri Oct 28, 2011
Nordberg

Michael Nordberg, MPA/HSA

Michael Nordberg, MPA/HSA, is the newly appointed associate dean of administration and finance for the UCSF School of Pharmacy.

In-flight programming features bioartificial kidney

Fri Oct 21, 2011
Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.

Fischbach receives Packard Fellowship

Mon Oct 17, 2011
Fischbach

Michael Fischbach, PhD

Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.

Giacomini cites increasing impact of quantitative pharmacology

Mon Oct 10, 2011
Giacomini
© majedphoto.com

Kathy Giacomini, PhD

Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department

Abate aided by QB3’s Startup in a Box program

Wed Sep 28, 2011
Abate

Adam Abate, PhD

Adam Abate, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine, Department of Bioengineering and Therapeutic Sciences, is a prime trial candidate for QB3’s Startup in a Box.

UCSF Center for Quantitative Pharmacology kicks off with 2-day Mission Bay symposium

Fri Sep 16, 2011
William J. Rutter Center at UCSF Mission Bay
The new UCSF Center for Quantitative Pharmacology housed within the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the Schools of Pharmacy and Medicine, will be inaugurated next week with a wide-ranging, 2-day conference, September 22 and 23, 2011 at William J. ...

Cantilena appointed new ACDRS course director

Fri Sep 2, 2011
Louis R. Cantilena, Jr., MD, PhD, is the newly appointed course director of the American Course on Drug Development and Regulatory Sciences (ACDRS) effective summer 2011.

Asthma genetics study finds new gene

Mon Aug 29, 2011
A novel gene associated with the asthma susceptibility in African Americans was revealed by a U.S. consortium of asthma genetics researchers, including Esteban G. Burchard, MD, MPH, Department of Bioengineering and Therapeutic Sciences,

Pages